UBS analysts estimate the global autonomous taxi market could be worth over $2 trillion annually by 2030:
This is an excerpt from a story delivered exclusively to Business Insider Intelligence Transportation & Logistics Briefing subscribers.
In fact, in April, Ford CEO Jim Hackett stated that Ford"overestimated the arrival of AVs." He furtherthat his company's autonomous taxis would be geo-fenced, limiting their availability,"because the problem is so complex." Even if technological capabilities catch up, providers still need to win wider regulatory approval and build consumer trust of AVs.
Without advancing in these areas, the mass adoption of autonomous taxis could be significantly delayed — UBS estimates that this could lead to having just 1 million vehicles on the road, significantly less than its more optimistic forecast of 11 million taxis.1. Sign up for the Transportation & Logistics Briefing to get it delivered to your inbox 4x a week.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Infrastructure Week dies — again"There wasn’t going to be a $2 trillion deal anyway," Republican Rep. Sam Graves said.
Baca lebih lajut »
Geoffrey Rush awarded $2 million in Sydney defamation caseOscar-winning actor Geoffrey Rush awarded $2 million in defamation case over reports he had been accused of inappropriate behavior toward an actress.
Baca lebih lajut »
This $2 app changed the way I work.NBCNewsBETTER: With the Pomodoro Technique, you pick a task, set a timer for 25 minutes to work on that one thing, take a 5-minute break when the timer rings and repeat.
Baca lebih lajut »
Gene therapy gets FDA approval -- and a $2 million price tagThe FDA approved a treatment for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2. The price tag? $2.125 million for a one-time treatment.
Baca lebih lajut »
U.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorderZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therap...
Baca lebih lajut »
Novartis $2 million gene therapy for rare disorder is world's most expensive drugSwiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA) and priced the one-time treatment at a record $2.125 million
Baca lebih lajut »
At $2 Million, New Novartis Drug Is Priciest EverNovartis said it plans to price its recently approved gene therapy at $2.125 million, making it the world’s most expensive medicine.
Baca lebih lajut »
The Swiss Surfer Behind $2 Billion Payments Startup Checkout.comGuillaume Pousaz has built a payments firm he acquired in 2009 into a highly valued transaction processor for fast-growing internet companies that is now expanding in the U.S. and moving into other financial services.
Baca lebih lajut »
'Jeopardy!' champion James Holzhauer passes $2 million markThe 34-year-old professional sports gambler from Las Vegas went into Final Jeopardy with a lead of more than $30,000 and was the only contestant who answered the 'Around the USA' clue
Baca lebih lajut »
'Jeopardy!' juggernaut James Holzhauer moves closer to $2 million winnings with 25th win'Jeopardy!' champ James continued his epic streak with his 25th consecutive victory Wednesday.
Baca lebih lajut »